Safety and antimicrobial resistance of mass administration of azithromycin in children in Nigeria—SARMAAN II
Published:
Resources: Project brief
We are supporting the scaling up of azithromycin administration to children aged 1–59 months across 11 states of Nigeria, to reduce cases and deaths from malaria, pneumonia and diarrhoea.
Malaria Consortium is supporting implementation in Adamawa, Gombe, Jigawa, Kaduna and Kebbi, using a dual platform approach to administer twice-yearly doses of azithromycin. The first dose uses the structure of the seasonal malaria chemoprevention (SMC) programme, while being administered separately from SMC. The second dose is being delivered six months later using existing neglected tropical disease (NTD) structures. We are overseeing implementation by partner organisations in an additional four states, leveraging the polio eradication programme and NTD mass drug administration structures to reach communities.